Cerebrospinal Fluid (CSF) Management Market : Technological Advancements & Worldwide Industry Analysis to 2023

Albany, NY -- (SBWIRE) -- 06/07/2017 -- Hydrocephalus is defined as an abnormal increase in the amount of cerebrospinal fluid inside the cranial cavity accompanied with enlargement of cerebral ventricles, which frequently leads to intracranial pressure and skull enlargement. Hydrocephalus majorly affects population aged 50 years and above. According to the World Population Prospects: the 2012 Revision (United Nations, Department of Economic and Social Affairs), the age group above 80 years, also referred as 'oldest old' in the report, was nearly 14% and is expected to increase to 19% by 2050. Earlier the treatment for hydrocephalus consisted of purging, bleeding, and puncturing of the ventricles to drain the fluid, surgical removal of fluid, application of cold wraps or plaster of herbs to the head, etc. There is no effective treatment for hydrocephalus. Diuretics such as Acetazolamide are medications prescribed to few hydrocephalus patients; however, these are temporary treatments. Hydrocephalus was considered a serious problem by neurosurgeons until the development of shunt valve. This transformed the quality of care for patients with hydrocephalus.